Authors:
AURICHE M
BERTRAND P
BLAY N
DANAN G
HAMEL JD
IMBS JL
LAGIER G
MICALEFF A
MOORE N
OLLAGNIER M
REVEILLEAURICHARD S
SOUBRIE C
WEBER F
Citation: M. Auriche et al., GOOD PHARMACOVIGILANCE PRACTICES AND PUBL ICATIONS OF CASE-REPORTS - DISCUSSIONS AND COMMENTS, Therapie, 52(2), 1997, pp. 123-127
Citation: E. Rothschild et al., RISK OF DIARRHEA DUE TO CLOSTRIDIUM-DIFFICILE DURING CEFOTAXIME TREATMENT - CEFOTAXIME COMPARES FAVORABLY WITH OTHER 3RD GENERATION CEPHALOSPORINS, BMJ. British medical journal, 312(7033), 1996, pp. 778-778
Citation: G. Danan et C. Benichou, CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .1. A NOVEL METHODBASED ON THE CONCLUSIONS OF INTERNATIONAL CONSENSUS MEETINGS - APPLICATION TO DRUG-INDUCED LIVER INJURIES, Journal of clinical epidemiology, 46(11), 1993, pp. 1323-1330
Citation: C. Benichou et al., CAUSALITY ASSESSMENT OF ADVERSE REACTIONS TO DRUGS .2. AN ORIGINAL MODEL FOR VALIDATION OF DRUG CAUSALITY ASSESSMENT METHODS - CASE-REPORTSWITH POSITIVE RECHALLENGE, Journal of clinical epidemiology, 46(11), 1993, pp. 1331-1336
Citation: G. Danan, CRITERIA OF DRUG-INDUCED LIVER DISORDERS - REPORT OF AN INTERNATIONALCONSENSUS MEETING, Gastroenterologie clinique et biologique, 17(5BIS), 1993, pp. 80000018-80000021
Citation: G. Danan et al., STANDARDIZED SCORING SYSTEM FOR CAUSALITY ASSESSMENT OF DRUG-INDUCED ACUTE LIVER-INJURY - PRESENTATION OF A WORKSHEET FOR CAUSALITY ASSESSMENT, Gastroenterologie clinique et biologique, 17(5BIS), 1993, pp. 80000022-80000024